Skip to main content

Adrian Felipe Hernandez

Duke Health Cardiology Professor
Medicine, Cardiology
Duke Box 3850, Durham, NC 27710
P.O. Box 17969, Durham, NC 27715

Current Duke Appointments & Affiliations


Duke Health Cardiology Professor · 2021 - Present Medicine, Cardiology, Medicine
Professor of Medicine · 2015 - Present Medicine, Cardiology, Medicine
Vice Dean and Executive Director of Duke Clinical Research · 2020 - Present Duke Clinical Research Institute, Institutes and Centers
Member in the Duke Clinical Research Institute · 2004 - Present Duke Clinical Research Institute, Institutes and Centers
Executive Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Institutes and Centers

Recent News Items


Published November 16, 2023
Which Duke Scholars Made the Most Cited List?
Published October 20, 2022
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
Published August 2, 2022
DCRI to Take Key Coordinating Role in the Study of Long COVID

View All News Items

Recent Scholarly Works


Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL.

Journal article Am Heart J · September 2026 BACKGROUND: In the EXSCEL trial, exenatide did not reduce major adverse cardiovascular events (MACE), but heterogeneity of benefit and the role of cardiac biomarkers remain uncertain. We evaluated the prognostic value of baseline and 1-year changes in N-te ... Full text Link to item Cite

A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in Diabetes.

Journal article JCI Insight · July 2, 2026 Adults with type 2 diabetes mellitus (T2DM) are at increased risk for stroke, myocardial infarction, and cardiovascular death, yet individual risk is heterogeneous and incompletely captured by clinical models. In the Exenatide Study of Cardiovascular Event ... Full text Link to item Cite

Association of blood pressure variability with clinical and biomarker outcomes in moderate to severe TBI: A TRACK-TBI study.

Journal article J Clin Neurosci · July 2026 INTRODUCTION: Traumatic brain injury (TBI) represents a significant global health burden and often results in functional impairment. Blood pressure variability (BPV), a surrogate marker of autonomic dysfunction, has been shown to influence outcomes in pati ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030

Increasing the Quality and Efficiency of Clinical Trials (U18)

ResearchInvestigator · Awarded by Food and Drug Administration · 2014 - 2029

Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029

View All Grants

Education


University of Texas, Dallas · 1997 M.D.